Risks and Benefits of Phase 1 Clinical Trials for Patients with Relapsed or Refractory Lymphoma, from 2008 to 2023
Hematological oncology(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined